Home | Supplements | Volume 42 | This supplement | Article number 3


Polio eradication in a chronic conflict setting lessons from the Republic of South Sudan, 2010-2020

Polio eradication in a chronic conflict setting lessons from the Republic of South Sudan, 2010-2020

Sylvester Maleghemi1,&, Ayesheshem Ademe Tegegne1, Melisachew Ferede1, Bassey Enya Bassey2, Godwin Ubong Akpan3, Isah Mohammed Bello4, Johnson Muluh Ticha3, Atem Anyuon5, Joy Luba Waya1, Samuel Oumo Okiror3, Modjirom Ndoutabe3, Kibebu Kinfu Berta1, Fabian Ndenzako1, Pascal Mkanda3, Olushayo Oluseun Olu1


1World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan, 2World Health Organization, Oyo State Office, Nigeria, 3World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo, 4World Health Organization, Inter-Country Support Team office for East and Southern Africa, P.O. Box 5160, Harare, Zimbabwe, 5Ministry of Health, Ministerial Complex, Juba, South Sudan



&Corresponding author
Sylvester Maleghemi, World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan




Introduction: in 1988 the World Health Assembly set an ambitious target to eradicate Wild Polio Virus (WPV) by 2000, following the successful eradication of the smallpox virus in 1980. South Sudan and the entire African region were certified WPV free on August 25, 2020. South Sudan has maintained its WPV free status since 2010, and this paper reviewed the country's progress, outlined lessons learned, and describes the remaining challenges in polio eradication.


Methods: secondary data analysis was conducted using the Ministry of Health and WHO polio surveillance datasets, routine immunisation coverage, polio campaign data, and surveys from 2010 to 2020. Relevant technical documents and reports on polio immunisation and surveillance were also reviewed. Data analysis was conducted using EPI Info 7 software.


Results: administrative routine immunisation coverage for bivalent Oral Polio Vaccine (OPV) 3rd dose declined from 77% in 2010 to 56% in 2020. In contrast, the administrative and post-campaign evaluation coverage recorded for the nationwide supplemental polio campaigns since 2011 was consistently above 85%; however, campaigns declined in number from four in 2011 to zero in 2020. Overall, 76% of notified cases of Acute Flaccid Paralysis (AFP) received three or more doses of the oral polio vaccine. The Annualized Non-AFP rate ranged between 4.0 to 5.4 per 100,000 under 15 years populations, and stool adequacy ranged from 83% to 94%.


Conclusion: South Sudan's polio-free status documentation was accepted by the ARCC in 2020, thereby enabling the African Region to be certified WPV free on August 25, 2020. However, there are concerns as the country continues to report low routine immunisation coverage and a reduction in the number of polio campaigns conducted each year. It is recommended that the country conduct high-quality nationwide supplemental polio campaigns yearly to achieve and maintain the required herd immunity. It invests in its routine immunisation program while ensuring optimal AFP surveillance performance indicators.



Introduction    Down

Poliomyelitis is a highly infectious disease caused by polio viruses and causes irreversible paralysis in children and adults [1]. The clinical manifestation is paralysis which occurs a few hours or days after contracting the virus. However, most polio cases are asymptomatic, which helps sustain its transmission through the faecal-oral route, with communities with poor hygiene and sanitation being at high risk [2,3]. The 41st World Health Assembly (WHA) held in 1988 adopted a resolution to eradicate polio globally [4]. Subsequently, the Global Polio Eradication Initiative (GPEI), a public-private partnership, was launched and tasked with ensuring support to all countries to eradicate the disease [5-7].

The GPEI has made tremendous progress since its establishment. As of 2020, the number of paralyses caused by WPV type 1 was 140, a reduction of over 99.9% from the original 350,000 reported in 1988 before eradication efforts were implemented [8-10]. Notably, two of the three strains of WPV that cause paralysis have been eradicated, with WPV type 2 declared eradicated in September 2015 and WPV type 3 in October 2019 [11-13]. The core strategies utilised in achieving these feats are high routine immunisation coverage, provision of supplementary Oral Polio Vaccine (OPV) doses through national immunisation days, strong Acute Flaccid Paralysis (AFP) surveillance system, and "mop ups", which are targeted polio campaigns in areas of poliovirus transmission [14]. As of December 2020, all but one of the World Health Origination (WHO) regions, the Eastern Mediterranean Regions, have been certified wild poliovirus (WPV) free, with cases reported from Pakistan and Afghanistan [15,16]. The African Region was certified WPV free in August 2020 following Nigeria's eradication of WPV type 1 in 2016 [17].

South Sudan has also made tremendous progress in the eradication of polio. The last indigenous wild polio virus type 1 case was reported in 2001 in Pariang County, Unity State [18]. Though indigenous wild poliovirus was interrupted in 2001, the country experienced two imported outbreaks of WPV in 2004-2005 and 2008-2009 from Nigeria via Sudan. The country's claim of being WPV free was accepted in June 2020. However, Vaccine-Derived Polio Virus (VDPV) outbreaks continue to be recorded in the country, with the most recent outbreak declared on 18 September 2020 by the Ministry of Health (MOH) in South Sudan [19].

Polio eradication in the chronic conflict setting of South Sudan faced several challenges, including difficult access due to insecurity and terrain, disrupted health systems, destruction and looting of health facilities, and poor infrastructure. The country continues to battle with a humanitarian crisis due to the cumulative effects of years of conflict, which have destroyed people's livelihoods. As of August 2020, the humanitarian situation report noted that 7.5 million people need humanitarian assistance, with 1.6 million internally displaced and another 2.26 million living as refugees in neighboring countries [20] with a weak health system largely dependent on donors and implementing partners. Surmounting these challenges required dedicated and trained personnel with innovative strategies and approaches that are not documented in the literature. Scientific publications on the progress, challenges and lessons learned remain scarce. This paper, therefore, reports the path towards polio eradication in South Sudan and contributes to global lessons learned and best practices in the eradication initiative. Findings from the South Sudan context could be extrapolated to other countries in conflict and accelerate the global polio eradication efforts.



Methods Up    Down

Study area: South Sudan is a landlocked country located in Eastern Africa. It covers approximately 640,000km2 with a projected population of 13.3 million using a 3.0% growth rate from the census figures for 2008 and a population density of 15 per square kilometre [21]. It is divided into ten states and further subdivided into 80 Counties and over 600 Payams. It attained independence on 9th July 2011, following more than two decades of civil war, with renewed civil conflicts occurring in December 2013 and again in June 2016, along with continuous fighting, which remains ongoing in the country [22]. The conflicts have spared no states or regions; however, three states, Jonglei, Unity, and Upper Nile, known as the former conflict-affected states, have felt the brunt the most and have undermined the health system's capacity to deliver essential health services. Still, despite the challenges, active surveillance of AFP cases in health facilities and communities continues facilitated by the partnership and huge polio workforce located at even the lowest level (Boma), which was well established in the country even before its independence.

Study design: we conducted a retrospective descriptive study of the polio eradication initiative in South Sudan from 2010 to 2020 through secondary analyses of quantitative data from the national polio database. Qualitative data were obtained through reviewing documents and reports on polio immunisation campaigns, AFP surveillance, and other polio eradication activities. Analysis of immunisation coverage rates included data from South Sudan District Health Information System (DHIS), WHO United Nations Children's Fund (UNICEF) Joint Reporting Form on Immunisation (JRF), and the WHO, UNICEF Immunisation Coverage Estimates (WUENIC). The polio supplemental campaign and surveillance data were obtained from the MOH and WHO databases.

Immunisation coverage and data: we used routine administrative coverage data for polio immunisation collected every month from approximately 1065 health facilities in 80 counties transmitted through the DHIS system to the national MOH database. Data on polio vaccination coverage were also retrieved from reports on the immunisation surveys and WUENIC. The polio campaign data were obtained from the tally sheets used during the campaigns and collated at all levels, with the final summary shared by states to the National level. Other data sets were analysed to determine the quality and extent of the campaign, including the post-campaign evaluations (PCEs) and lot quality assurance sampling (LQAS). Two vaccines protect against the poliovirus, the Oral Polio Vaccine (OPV) and Injectable Polio Vaccine (IPV). A child is said to be fully vaccinated against the poliovirus when OPV3 and IPV are recorded on their vaccination card. Oral polio vaccine (OPV3) is the third time a child receives an oral polio vaccine, excluding the OPV birth dose and given along with the IPV at 14 weeks or later. IPV was added to the immunisation schedule in Dec 2015. The country conducts supplementary immunisation campaigns using OPV. All children under five of age are targeted and given two drops of the polio vaccines irrespective of the child's polio vaccination status, which boosts polio herd immunity. Results are collated against set targets, with an evaluation done to determine the coverage and quality of the campaign

Acute flaccid paralysis (AFP) surveillance: the AFP surveillance system in South Sudan relies on health facilities and community-based reporting. The system detects, notifies, investigates, and verifies AFP cases in children under 15 years old or in any person a clinician suspects poliomyelitis. In South Sudan, it involves over 4500 personnel. It is a partnership between community members, Non-Government Organisations (NGOs), International Non-Government Organisations (INGOs), Civil Societies (CSO), the Rotary, and United Nations (UN) organisations led by the MOH South Sudan. There are two main AFP surveillance indicators, non-polio AFP (NP-AFP) rate, cases of acute flaccid paralysis not due to polio per 100,000 children less than 15 years with an NP-AFP rate of ≥2 agreed as the country's standard, being able to detect the poliovirus, and the stool adequacy, with 80% of the stool being adequate as the standard [23,24]. Adequate stool means that the stool must be collected within 14 days of onset of the paralysis and transported to a WHO accredited lab under a good reverse cold chain [24]. Apart from the two main polio surveillance indicators, another indicator that determines the quality of the AFP surveillance system is the non-polio enterovirus rate (NPENT). This determines the ability of the laboratory to report the poliovirus or any other virus if present in the AFP stool sample with a benchmark of 10% [25].

When a person meets the community AFP case definition, the sudden weakness of any limbs, two stool samples are collected with at least a 24-hour interval between stool collection, under the appropriate reverse cold chain. South Sudan transports all AFP samples from the states to the capital, Juba, via aeroplanes. From Juba, the AFP samples are flown to the Uganda Virus Research Institute laboratory (UVRI), a WHO accredited polio laboratory, for analysis. All AFP cases have a case-based form completed, including clinical and epidemiological information. Records are stored in a centralised MS Access Database by the WHO data manager, with a copy retained at the National Public Health Laboratory Juba. Detailed case investigation (DCI) is conducted for all reported AFP cases to authenticate if it is a true AFP case by senior WHO and MOH EPI officers. Follow-up of inadequate cases, "cases investigated after 14 days of paralysis or with inadequate samples collected," is conducted by senior officers and clinicians using detailed investigation forms entered the Open Data Kit (ODK, including its website) mobile platform and uploaded into the national database. The National Polio Expert Committee (NPEC) meets quarterly and classifies all inadequate cases while endorsing adequate cases classified by the secretariat and making applicable adjustments. Laboratory results are entered into the database for completeness as soon as received from the URVI. We analysed retrospectively the AFP database stored at the national level that was routinely collected from all states during the study period.


Review of literature: PubMed, Global Health, and Google Scholar databases were searched for original peer-reviewed articles describing polio eradication efforts in South Sudan published from 2002 to 2020. The following combinations were used as keywords to search for literature on polio: 'polio' and a combination of the following words in permutations - 'eradication + surveillance + South Sudan', 'vaccination + South Sudan'. The search yielded three articles, of which none were considered relevant because the content focused on other vaccines and not the oral or injectable polio vaccines. Additionally, all available country, regional and global reports on immunisation for the period of 2002 to 2020 was reviewed. Published and unpublished reports on AFP surveillance and immunisation data reported by the South Sudan Ministry of Health were studied, along with annual progress reports on poliomyelitis eradication activities submitted to the ARCC (2014-2020) and quarterly reports from the Polio eradication committees, which were also reviewed.

Data analysis: the database for this study was from the DHIS, a web-based open-source software platform for reporting, analysis, and dissemination of data for all health programs in the country, which was exported to MS Excel. The WHO and UNICEF for estimating global, country by country, infant immunisation coverage (WUENIC) [26], web-based, MOH campaign database, immunisation surveys, and AFP surveillance case-based database access based, all exported to Microsoft excel for validation, cleaning, and analysis. Statistical data analysis was conducted using Epi Info statistical software (version 7; CDC, Atlanta, United States). Descriptive analyses were performed to describe the epidemiology of reported AFP cases in South Sudan, and statistics based on the WHO recommended performance indicators for AFP surveillance were generated [27]. Mapping was done to visualise surveillance performance and distribution of AFP cases by location using the ArcGIS Pro software. Results of the study are presented in the form of tables and maps. Qualitative analysis for the study used reports compiled from the Annual Polio reports, the 2019-2020 Polio free documentation, and yearly GAVI Joint Appraisals and supervisory reports. These reports were reviewed, and a strengths, weaknesses, opportunities, and threats (SWOT) analysis of the polio programme was developed based on methods from Wijingaarden [28].

Ethical approval and consent: the Ministry of Health approved this study. We used secondary data collected and stored at WCO and MOH. Administrative clearance for publication of this editorial was provided by the Ministry of Health of South Sudan and WHO (ePub-IP-00331505-EC) to publish the result. Moreover, the Research Ethics Review Board of the Ministry of Health provided clearance for the publication of manuscript under (MoH/RERB/D.03/2022) clearance number.



Results Up    Down

Routine immunisation coverage: according to the MOH DHIS data, national administrative vaccination coverage for OPV3 ranged from 43% to 77% between 2010 and 2020. Injectable polio vaccine coverage was between 1% and 53% from 2016 to 2020 (Figure 1). A disparity exists even though both vaccines are administered simultaneously (Figure 1). The routine immunisation coverage has continued to decline from 2011, reaching its lowest level in 2016 and 2019, with administered coverage at 43% and 44%, respectively. Data from the EPI survey coverage to independently assess the EPI coverage, directly from the household conducted in the country in 2012 and 2017, estimated the OPV3 coverage to be 55% and 49%, respectively. A discrepancy of 10% was noted between the OPV3 administrative coverage and survey. The WUENIC report since 2010 showed that the OPV3 coverage has been below 60% since the conflict started in 2013 and has stagnated at 50% since 2018. The OPV3 administrative coverage is usually higher than the WUENIC report.

At the state level, the OPV3 administrative coverage ranged between 12% and 124% between 2015 to 2020 (Table 1), with the three-former conflict-affected states of Jonglei, Unity, and Upper Nile accounting for states with the lowest OPV3 coverage with an 11-year average immunisation coverage of 33%, 46%, and 34% respectively. The other seven states continued to record varying and inconsistent OPV 3 coverage, with Central Equatoria and Warrap having the highest 11 years average coverage of 81% and 80%, respectively. In 2020 administrative routine immunisation data for OPV3 showed that 21 (26%) counties recorded coverage of OPV3 greater than 80%, 22 (28%) between 50-79.99%, 26 (33%) between 25-49.99% and 11 (14%) counties had OPV 3 coverage of less than 25% (Figure 2). Counties with the lowest coverage are found in Unity, Jonglei and Upper Nile states; however, two counties from Eastern Equatoria and Central Equatoria reported less than 25% in 2020.

Supplemental immunisation coverage: the country conducts four rounds of supplementary immunisation campaigns using polio vaccines yearly. All children under five of age are targeted and given two drops of the polio vaccines irrespective of the child's polio vaccination status, which boosts polio herd immunity. Results are collated against set targets, with an evaluation done to determine the coverage and quality of the campaign. The country has conducted over 32 OPV campaigns since 2011. Table 2 shows the administrative data obtained directly from the vaccinators' record and post-campaign evaluation (PCE); data obtained from independent assessors was conducted two days after the nationwide polio campaigns. The administrative results ranged from 77% to 111%, while the PCE results obtained from independent monitors ranged from 81% to 97%. Table 2 shows that the number of rounds declined from four in 2011 to two in 2019 and none in 2020. The last polio countrywide supplemental immunisation activities (SIAs) were conducted in 2019 and achieved a coverage rate of 100%; however, post-campaign evaluation (PCE) showed coverage of 92%. However, in rounds 4, 2016 and round 1, 2018, the PCE was higher than administrative data. Table 3 shows the administrative and PCE results by state, with Upper Nile recording the lowest admin coverage of 22% and Central Equatoria with the highest admin coverage of 117%. Table 3 also showed that post-campaign evaluation was not conducted for some of the conflicts affected states rounds even though an SIA was done.

Immunity profile for non-polio AFP cases: a dataset of AFP surveillance comprised 3970 AFP cases notified from 2010 to 2020, of which 3161 (80%) of the cases were aged 0 to 59 months. Overall, 3182 (80%) of notified AFP cases had received more than three doses of the oral polio vaccine, and the polio vaccination status was zero for 332 (8%) of the AFP cases (Figure 3). The proportion of AFP cases with more than three OPV doses varied between 65% and 91% between 2010 to 2020, with the lowest rates observed in 2020 (65%), while the highest percentage was observed in 2016 (91%).

AFP surveillance indicators: from 2010 to 2020, South Sudan maintained the two main indicators of AFP surveillance, well above recommended standard, with the NP-AFP rate above 3/100,000 children under 15 years of age and reaching an NP-AFP rate of 5.36/100,000 for 2020, with the NP-AFP ranging from 3.89 to 5.5, with the highest number reported in 2018 (Figure 4). Likewise, stool adequacy has been above the certification level (80%) since 2010 and was 83% for 2020, with the best performance recorded in 2019. The URVI laboratory reports above the recommended standard of 10% NPENT since 2010, with the highest NPENT rate of 21.5% recorded in 2019 and the lowest NPENT rate of 13.2% recorded in 2018 (Table 4).



Discussion Up    Down

South Sudan's polio eradication program has seen its share of successes and setbacks, with routine immunisation suffering the most. Two vaccines, the OPV and the IPV protect against wild poliovirus and are both routinely administered in the country [29,30]. The outcomes of this study indicated that routine immunisation coverage continues to drop and is significantly below the required coverage of OPV3 and IPV of 80%. WUENIC reports and two independent EPI coverage surveys undertaken in 2012 and 2017 corroborate this conclusion [31,32]. The consistent low coverage between 2015 and 2020 can be attributed primarily to the conflict. This has weakened the health system, particularly at the peripheral level, with far-reaching negative consequences for engaging, retaining, and motivating adequate skilled health workers to deliver quality immunisation services [33,34]. However, the severe dips in 2014 and 2016 are explained by the massive conflict in 2013. Similar findings have been reported in conflict-affected nations such as the Syrian Arab Republic and Ukraine, with vaccination coverage declining by 50% [35].

Many health services in the country are provided in collaboration with partner organisations. However, in 2019, there was a delay in contract signing between the MOH and these partners, affecting many health services for nearly six months, as evidenced by the lowest coverage ever reported in the country that year. The three-former conflict-affected states of Jonglei, Unity and Upper Nile bore the major conflict's brunt. They continuously reported the lowest routine immunisation coverage, with most health facilities vandalised. There are also challenges in the vaccine supply chain, depleted human resources, and high population displacement and movement, with none of their counties reporting coverage above 80%. The increased coverage of >100% in Central Equatoria and Warrap states in 2013 and 2014 can be attributed to the massive population movement to safer havens. The disparity between administrator coverage, the EPI survey, and WUENIC demonstrates that data quality is a concern. The country is now conducting training sessions and quarterly data quality assessments to identify and close this gap. The country's general poor coverage is comparable to that of several other nations involved in the conflict, including Pakistan, Afghanistan, Yemen, Somalia, and the Democratic Republic of the Congo [36,37]

It is critical to recognise that the three states of Unity, Jonglei, and Upper Nile will require a more tailored strategy to increase RI coverage and mitigate the danger of polio epidemics. These states have suffered the most from the conflict, as these were where the fighting was most intense as facilities were burnt and people displaced with its attendant poor RI coverage. The country undertakes Supplemental Immunisation Activities (SIAs) through National Immunisation Days (NIDs), each cycle targeting about 3 million children aged <5 years to supplement the herd immunity produced by routine vaccination. These campaigns occur 4 times a year and are conducted door-to-door with vaccinators stationed at vehicle parks, schools, and border crossings to guarantee no child is missed. This approach has been highly successful, with coverage rates >85% commonly reported and verified by third-party post-campaign evaluations. It is worth noting that NIDs remain the only source of immunisation services in many sections of the country. This is supported by an analysis of children <5 years of age reporting AFP, which indicates that, on average, 80% of AFP cases received three or more doses during the polio campaigns from 2010 to 2020. Population immunity to polio may be higher than reported administrative coverage due to the numerous polio campaigns conducted.

Only three campaigns have been conducted in the last three years, two of which were subnational immunisation days targeting states with low RI administrative coverage. This has led to a reduction in the number of < 5-year-old children from AFP cases receiving three or more doses of OPV vaccine. This figure was lowest in 2020, with only 65% of reported AFP cases receiving three or more OPV doses due to the absence of polio campaigns which were halted due to the COVID 19 pandemic [38]. Because of campaign reductions, the decline in herd immunity will make the country vulnerable and or susceptible to another WPV importation, as reported in 2006 and 2008. Administrative results for the campaigns show that there is not much difference in coverage between the states, except for Upper Nile which consistently reported low coverage due mainly to access and insecurity. At the peak of the conflicts from 2014 to 2016, nationwide polio campaigns were not held for the former conflict states of Jonglei, Upper Nile and Unity as access was impossible due to insecurity; however other tailored approaches such as subnational campaigns and hit and run were conducted. The campaign's administrative results can be attributed to the quality of the pre-implementation activities, including micro plans, adherence to team selection criteria when recruiting team members, appropriate social messages with minimal non-compliance, and collaboration with partners led by the MOH. Also, the use of innovative tools such as the ODK for reporting performance and, most importantly, institutional memory, as the country has extensive experience in conducting similar campaigns. The high coverage in polio campaigns has proven challenging to transfer to RI, and the same has been recorded in other conflict-affected countries such as Somalia and warrants additional investigations [39].

South Sudan has consistently met the two core AFP surveillance indicators between 2010 and 2020, with improvements noted in the last three years attributed to the scaling-up of the community surveillance system in hard-to-reach states by the CORE group and access for humanity. Innovations such as the Open data kit, which uses mobile phones to provide real-time data for action and serve as the foundation for the programme's accountability framework [6]. The country reported 12 wild poliovirus outbreaks in 2004-2005 and 64 in 2008-2009. It reported 2 and 50 circulating Vaccine-Derived Polio Virus (cVDPV) outbreaks in 2014 and 2020, respectively, demonstrating a sound surveillance system while pointing to low herd immunity against polio virus.

South Sudan's AFP surveillance indicators are higher than the regional average for East and Southern African countries, with an NP-AFP at 5.1 and stool adequacy at 90% compared to the region's NP-AFP at 3.3 and stool adequacy at 86% [40]. This is due to the significant investment made by donors and the GPEI collaboration and the limited reliance on the current government health system, which is based on a passive surveillance system. Conflicts appear to have little effect on the ability to detect AFP cases and meet standard indicators, with similar results reported in countries such as Pakistan, Afghanistan, and Nigeria [39,41,42] The program's ability to detect and report the presence or absence of poliovirus is contingent upon the laboratory's ability to isolate and identify enteroviruses from AFP samples. These are affected by the reverse cold chain, with a 10% NPEV isolation rate serving as a reference point [43]. The country met the criterion for this indicator, further establishing the credibility of the country's polio activities despite delays in stool transfer to WHO-accredited laboratories caused by erratic flight schedules and cancellations, particularly during the rainy season. Transportation of AFP samples to the URVL on time continues to be the most significant barrier to the country's polio program. However, it can be addressed by ensuring that samples are adequately preserved until transported to the laboratory.

The findings of this study should be interpreted in the context of several limitations. First is the incompleteness and varied timeliness of the routine immunisation data. Second, the target population used remains data from the extrapolated 2008 Census. To overcome this, the RI data was the final database submitted in subsequent years, e.g. the 2020 data used was sourced from the DHIS database of March 2021. Also, data from the polio campaign micro plans collated from the community via a bottom-top process are used for campaign planning. For surveillance data, incomplete variables were excluded from any analyses; also, we conducted data harmonisation between different partners for consistency. The country routinely validates all AFP cases by senior and trained personnel. The introduction of the ODK in 2017 has helped mitigate some of the above limitations and the monthly data harmonisation at the National, state, and county levels. Second, the AFP cases reported through the polio surveillance system may not reflect the actual numbers of all AFP cases in the country. The major factors responsible are no reporting or investigation of these cases by the caregivers or health workers due to lack of knowledge and difficulty reporting due to poor or no mobile network. These are mitigated by yearly training of health workers and community informants. Third, the high NP-AFP rate does not imply that these are all true AFP cases, but this has been addressed by validating all AFP cases by senior WHO officers.



Conclusion Up    Down

South Sudan continues to report low immunisation coverage threatening polio achievements. Polio eradication is possible even in conflict settings with limited health service capabilities; however, post-certification guidelines set by GPEI must be followed to avoid a resurgence of the poliovirus. As GPEI comes to an end, it is essential to bring innovative ideas to improve routine immunisation coverage quickly. Of concern is the reduction in the number of polio campaigns which provides an opportunity for children to be immunised with OPV and an opportunity for sensitisation of caregivers on the need for immunisation.

Recommendations: we recommend that these polio campaigns be maintained with at least two national campaigns every year until RI coverage improves. Human resources are the most asset of the polio programme and need to be adequately supported as the GPEI ramps down with a decline in funding. The AFP surveillance system must be maintained post-certification, as the country's IDSR moves from the passive mechanism to the active search done for AFP surveillance. As the country continues to build and improve the healthcare infrastructure, there is a need for continued AFP surveillance to detect and respond to poliovirus outbreaks Tailored strategies such as Periodic Intensified Routine Immunisation (PIRI), Enhanced mobile and outreach interventions, missed opportunities for vaccination need to be adopted for RI use in the country, and proper compensation and security provided for health workers.

What are the implications for Public health?

Polio free certification is just the first of many steps towards achieving a polio-free world. Conflict countries like South Sudan still need to conduct high-quality polio campaigns, strengthen its AFP surveillance system for many more years as the current routine immunisation coverage will be unable to provide herd immunity required to stop the importation of the poliovirus in the country.

What is known about this topic

  • As of 2020, only one WHO region is yet to be certified wild poliovirus free, and the countries in this region (Afghanistan and Pakistan) along with South Sudan have suffered years of conflict; however, South Sudan has succeeded in getting its claim of being wild poliovirus free validated and accepted;
  • The country continues to report low routine immunisation coverage, less than the expected 80% for all vaccines, including both OPV and IPV
  • Injectable polio vaccine was introduced in 2016 following the switch from tOPV to bOPV.

What this study adds

  • It elaborates how WPV free certification can be achieved even in conflict countries and how the application of tested polio strategies can stop the virus on its track;
  • The importance of polio campaigns in maintaining herd immunity;
  • It identifies states and counties that need to be prioritised where resources are limited.



Competing interests Up    Down

All authors declare no competing interests.



Authors' contributions Up    Down

SM conceived and drafted the article and systematically reviewed the literature, while AAT, MF, BEB, GUA, IMB, JMT, AA, JLW, SOO, MN, FN, KKB, PM, and OOO critically reviewed and approved the final version of the study.



Acknowledgments Up    Down

The authors would like to thank all health workers, partners, and donors who have supported the country's quest for polio certification. Special thanks go to Megan Peck who also made valuable inputs. The authors alone are responsible for the views expressed in this article, which do not necessarily represent the institutions' views, decisions, or policies with which they are affiliated.



Tables and figures Up    Down

Table 1: routine immunisation: oral polio vaccine 3rd dose administration coverage by state 2010 - 2020, South Sudan

Table 2: comparison of administrative and post campaign evaluation results of supplemental immunisation activities conducted 2011 - 2020

Table 3: results of polio campaigns 2013-2019, South Sudan

Table 4: non-polio enterovirus rate of acute flaccid paralysis samples 2010-2020, South Sudan

Figure 1: oral polio vaccine 3rd dose/ injectable polio vaccine immunisation coverage 2010-2020, South Sudan

Figure 2: oral polio vaccine 3rd dose routine immunisation administration coverage by county, South Sudan 2020

Figure 3: immunity profile for non-polio - AFP cases (6-59 months) 2010-2020 South Sudan

Figure 4: the two main acute flaccid paralysis surveillance indicators 2010-2020, South Sudan



References Up    Down

  1. World Health Organization. Poliomyelitis. Accessed December 5, 2021.

  2. World Health Organization. The immunological basis for immunisation series. 2019.

  3. Lien G, Heymann DL. The problems with polio: toward eradication. Infect Dis Ther. 2013 Dec;2(2):167-174. PubMed | Google Scholar

  4. World Health Organization. Seventieth world health assembly update, 25 May. Accessed December 5, 2021.

  5. Centre for Public Impact. The Global polio eradication initiative (GPEI). 2016. Accessed December 5, 2021.

  6. Bassey BE, Vaz RG, Braka F, Komakech W, Maleghemi ST, Akpan GU et al. Profiling the immunity status of children with non-polio acute flaccid paralysis who had not received any doses of oral polio vaccine in the South-South region, Nigeria 2011-2014. Public Health. 2016 Oct;139:148-153. PubMed | Google Scholar

  7. Maleghemi S, Enya Bassey B, George B, Usman A, Anthony K, Bassey E. Improving Acute Flaccid Paralysis (AFP) surveillance performance in South Sudan: the contribution of open data kit mobile data collection technology. Am J Epidemiol Infect Dis. 2019;7(1):11-15. Google Scholar

  8. Our world in data. Polio. Dattani S, Spooner F, Ochmann S, Roser M. 2017. Accessed December 5, 2021.

  9. Aylward RB, Hull HF, Cochi SL, Sutter RW, Olivé JM, Melgaard B. Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ. 2000;78(3):285-97. PubMed | Google Scholar

  10. Global Polio Eradication Initiative. Global wild poliovirus analysis 2015-2020. Accessed December 5, 2021.

  11. Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF et al. Progress toward polio eradication-worldwide, January 2017-March 2019. MMWR Morb Mortal Wkly Rep. 2019 May 24;68(20):458-462. PubMed | Google Scholar

  12. Moffett DB, Llewellyn A, Singh H, Saxentoff E, Partridge J, Iakovenko M et al. Progress toward poliovirus containment implementation - worldwide, 2018-2019. MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):825-829. PubMed | Google Scholar

  13. Global polio eradication initiative. Two out of three wild poliovirus strains eradicated. 2019. Accessed March 8, 2020.

  14. World Health Organization. Global polio eradication initiative strategic plan 2004-2008 WHO partners in the global polio eradication initiative. 2003. Google Scholar

  15. Global Polio Eradication Initiative. When could the Eastern Mediterranean Region be free of wild poliovirus? Accessed May 15, 2020.

  16. World Health Organization. Statement of the twenty-third IHR emergency committee regarding the International spread of poliovirus. 2020. Accessed March 8, 2020.

  17. World Health Organization-Nigeria. Three years without a case of wild polio virus, Government of Nigeria warns against complacency. August 21, 2019. Accessed May 25, 2020.

  18. WHO EMRO. Sudan: polio eradication initiative. Accessed May 15, 2020.

  19. Global Polio Eradication Initiative. South Sudan. Accessed December 6, 2021.

  20. OCHA. South Sudan. Accessed April 2, 2022.

  21. The World Bank. South Sudan household survey 2010. Accessed May 15, 2020.

  22. International Crisis Group. Toward a viable future for South Sudan. 2021. Accessed April 29, 2022.

  23. Gardner TJ, Diop OM, Jorba J, Chavan S, Ahmed J, Anand A. Surveillance to track progress toward polio eradication-Worldwide, 2016-2017. MMWR Morb Mortal Wkly Rep. 2018 Apr 13;67(14):418-423. PubMed | Google Scholar

  24. Global Polio Eradication Initiative. Surveillance Indicators. Accessed June 30, 2021.

  25. Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009-2013. BMC Public Health. 2014 Jul 5;14:687. PubMed | Google Scholar

  26. World Health Organization. Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage. 2021. Accessed April 29, 2022.

  27. Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I et al. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect Dis. 2020 Aug 18;20(1):611. PubMed | Google Scholar

  28. Van Wijngaarden JDH, Scholten GRM, Van Wijk KP. Strategic analysis for health care organisations: the suitability of the SWOT-analysis. Int J Health Plann Manage. Jan-Mar 2012;27(1):34-49. PubMed | Google Scholar

  29. Creese AL, Henderson RH. Cost-benefit analysis and immunisation programmes in developing countries. Bull World Health Organ. 1980;58(3):491-497. Google Scholar

  30. WHO/Europe. Poliomyelitis (polio) and the vaccines used to eradicate it - questions and answers. Accessed June 28, 2021.

  31. World Health Organization. Poliomyelitis vaccination coverage. 2021. Accessed April 29, 2022

  32. Mbabazi W, Lako AK, Ngemera D, Laku R, Yehia M, Nshakira N. Maiden immunisation coverage survey in the republic of South Sudan: a cross-sectional study providing baselines for future performance measurement. Pan Afr Med J. 2013 Nov 23;16:110. PubMed | Google Scholar

  33. Abuagla A, Yousif N, Badr E. Understanding the labour market of human resources for health in sudan. 2013. Google Scholar

  34. Grundy J, Biggs BA. The impact of conflict on immunisation coverage in 16 countries. Int J Heal Policy Manag. 2019;8(4):211-221. PubMed | Google Scholar

  35. Nnadi C, Etsano A, Uba B, Ohuabunwo C, Melton M, Wa Nganda G et al. Approaches to vaccination among populations in areas of conflict. J Infect Dis. 2017 Jul 1;216(suppl_1):S368-S372. PubMed | Google Scholar

  36. Sato R. Effect of armed conflict on vaccination: evidence from the Boko haram insurgency in northeastern Nigeria. Confl Health. 2019 Oct 29;13:49. PubMed | Google Scholar

  37. Mashal T, Nakamura K, Kizuki M, Seino K, Takano T. Impact of conflict on infant immunisation coverage in Afghanistan: a countrywide study 2000-2003. Int J Health Geogr. 2007 Jun 7;6:23. PubMed | Google Scholar

  38. MOH SS. AFP surveillance update South Sudan week 10, 2021.

  39. Mbaeyi C, Kamadjeu R, Mahamud A, Webeck J, Ehrhardt D, Mulugeta A. Progress towards polio eradication-Somalia, 1998-2013. J Infect Dis. 2014 Nov 1;210 Suppl 1(01):S173-80. PubMed | Google Scholar

  40. Manyanga D, Byabamazima C, Masvikeni B, Daniel F. Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012-2019. Pan Afr Med J. 2020 Jun 8;36:71. PubMed | Google Scholar

  41. Morales M, Tangermann RH, Wassilak SGF. Progress toward polio eradication - Worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):470-3. PubMed | Google Scholar

  42. Bigna JJR. Polio eradication efforts in regions of geopolitical strife: the Boko Haram threat to efforts in sub-Saharan Africa. Afr Heal Sci. 2016;16(2). Google Scholar

  43. Bassey E, Akpan GU, Okocha-ejeko A. Assessment of the quality of the reverse cold chain management in the Acute Flaccid Paralysis (AFP) surveillance system for polio eradication; South-south Zone, Nigeria 2015. American Journal of Epidemiology and Infectious Disease. 2016;4(5):100-104. Google Scholar